Download Chronic liver disease

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
Chronic liver disease
Definition
• Pathologic
o Liver biopsy showing features of chronic inflammation or
cirrhosis (Metavir, Knodell’s Scoring…)
• Etiology
• Clinical
o Features of chronic liver stigmata, complications
including portal hypertension
Etiology
•
•
•
•
•
•
•
•
•
Infection
Alcohol
Autoimmune
Cholestatic
Infiltrative
Metabolic
Vascular
Drugs
Cryptogenic
Viral Hepatitis
Over View
Virus
Transmission
Chronicity
A
Feco-oral
No
B
Percutanous
per mucosal
Yes
C
Percutanous
per mucosal
Yes
D
Percutanous
per mucosal
Yes
E
Feco-oral
No
Diagnosis
• Medical history (parenteral risk factors)
• Investigations
o Biochemical
 Serology( HBsAg, HBeAg, HCV Ab, HDV Ab, PCR)
 LFT,CBC,PT
o Radiologic imaging (Ultrasound, CT/MRI abdomen)
o Pathology (Liver biopsy with features of chronic hepatitis or
cirrhosis)
Alcohol
Alcoholic liver disease:
• Steatosis
• Acute alcoholic steatohepatitis
• cirrhosis
Depends on:
o Consumed alcohol
o Duration
o Genetic predisposition
Autoimmune Hepatitis
• Diagnosis
o Autoantibody (ANA, SMA, LKM1 Ab..)
o IgG (Increased)
o Liver biopsy (interface hepatitis)
Cholestatic liver disease
• Primary biliary cirrhosis
o AMA positive, increased Ig M & ALP
• Sclerosing cholangitis
o Increased ALP, association with IBD
o ERCP showing beading of biliary ducts
Hepatic vascular disorder
• Budd-Chiari syndrome
(triad of tender hepatomegaly, ascites & spleenomegaly)
• Portal vein thrombosis
• Veno-occlusive disease
Drug induced liver disease
• Cholestatic
Antidepressant, ant seizure, anti fungal agents
• Granulomas
Allopurinol, pheytoin
• Fibrosis
Methotrexate, organic solvents
• Phospholipidosis
Amiodarone, TPN, septrin
• Steatosis
Tetracycline, glucocorticoids
• Vascular
Estrogens, azathioprine
• Adenomas
Estrogens
Metabolic liver disease
• NASH
o Risk factors : insulin resistance
primary: (obesity, type II diabetes, dyslipidemia)
secondary: (drugs, short bowel syndrome, TPN, metabolic)
o Stages:
•
•
•
•
I: Steatosis (macro vesicular)
II: Steatosis + inflammation (centrilobular)
III: Steatosis + inflammation + ballooning (degeneration & necrosis)
IV: Steatosis + inflammation + ballooning + fibrosis +/- Mallory
bodies
Metabolic liver disease
• Alpha 1-Antitrypsin Deficiency
o Liver and lung involvement
o Diagnosis using quantitative serum alpha 1-antitrypsin & liver biopsy (PAS+,
diastase resistant globules in periportal hepatocytes)
• Hereditary Hemochromatosis
o Increased iron absorption & deposition in liver, pancreas, skin, joints &
heart
o Increased transferrin saturation & Ferritin. HFE mutation analysis & liver
biopsy ( increased hepatic iron index >1.5 with >+2 Perls’ Prussian blue
stain)
• Wilson’s Disease
o Autosomal recessive with copper accumulation in liver, brain, cornea, RBCs,
o
kidneys & joints due to defective copper transport and excretion.
Serum ceruloplasmin is decreased with increased urinary & hepatic copper
Signs & Symptoms
• Encephalopathy
• Jaundice
• Pallor
• KF ring
• Xanthelasma
• Parotid swelling
• Fetor hepaticus
• Bleeding gums
• Clubbing
• Leukonychia
• Palmer erythema
• Dupetryns contracture
• Asterexis
• Gynecomastia
• Scratch marks
Complication
• Ascites
• GI bleed
• SBP
• Edema
• Hepatoma
Related documents